(Q84918584)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Effect of related donor availability on outcome of AML in the context of related and unrelated hematopoietic cell transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

M Yanada

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

S Kurosawa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

T Yamaguchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

N Uchida

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

S Miyawaki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

H Kanamori

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

K Usuki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

T Kobayashi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

M Watanabe

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

K Nagafuji

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

S Yano

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Y Nawa

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

J Tomiyama

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

H Tashiro

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Y Nakamura

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

S Fujisawa

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

F Kimura

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

N Emi

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

I Miura

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

T Fukuda

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

3 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

12 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

390-395

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22941379%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2012.159

12 February 2020

exact match

0 references

cites work

Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.159

7 January 2021

The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Grup

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.159

7 January 2021

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.159

7 January 2021

Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.159

7 January 2021

Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia: results of the JALSG AML97 study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.159

7 January 2021

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.159

7 January 2021

Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.159

7 January 2021

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.159

7 January 2021

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.159

7 January 2021

A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.159

7 January 2021

Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.159

7 January 2021

Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.159

7 January 2021

Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.159

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.159

7 January 2021

Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.159

7 January 2021

Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.159

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.159

7 January 2021

Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.159

7 January 2021

Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.159

7 January 2021